Management sees German medical market quadrupling as it awaits key EU certification and works to boost production capacity.

Q1 2025 Earnings Call Transcript February 11, 2025 OrganiGram Holdings Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.03. Operator: Good morning. My name is ...

Following the company’s first quarter results, Haywood analyst Neal Gilmer has cut his price target on Organigram.

On Tuesday, Cannabis producer Organigram Holdings Inc reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million. 21% of harvests came ...

Cannabidiol Market Share 2025 Cannabidiol Market is estimated to be valued at USD 8.12 Bn in 2024 and is expected to reach USD 23.41 Bn by ...

OrganiGram Holdings Inc (OGI) reports a 17% increase in net revenue and strategic international expansion, despite facing ...

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Organigram (OGI) to C$3 from C$4.25 and keeps a Buy rating on ...

Shopify's profit doubled in the fourth quarter after revenue rose by nearly a third, boosted by strong sales during the holidays and deeper integration with more online merchants. Shares have been ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/18.BgH5HSOh.js ...

OrganiGram Holdings Inc (TSX:OGI). reported a significant improvement in its financial performance for the third quarter of fiscal year 2024, with a 25% year-over-year increase in net revenue. The ...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the first quarter ended ...

Asked about international market competition and potential price compression. CEO Goldenberg acknowledged competitive pressures but highlighted the advantages of Moncton's low-cost, high-quality ...